Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06410209 · ClinicalTrials.gov registry record · Phase 2

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

A Phase 2 study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, sponsored by Children's Oncology Group.

Recruiting
Registry status
Phase 2
Development phase
190
Enrollment target
20
Study locations

NCT06410209 is a Phase 2 study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm that is actively recruiting participants, run by Children's Oncology Group. The registered enrollment target is 190 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06410209, a Phase 2 study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, is actively recruiting participants, sponsored by Children's Oncology Group.

RECRUITING
Registry status
Phase 2
Development phase
190 participants
Enrollment target
20
Study locations

Study Summary

This clinical trial tests the impact of a culturally-tailored home-based physical activity program on physical fitness in Hispanic or Latino/Latina adolescent and young adult (AYA) childhood cancer survivors. After treatment for cancer, some AYA survivors experience long-term effects from the cancer and its treatment including weight gain, fatigue and decreased physical fitness. Hispanic or Latino/Latina survivors may have a higher risk of these effects compared to non-Hispanics. Regular physical activity helps maintain healthy weight, energy levels and overall health. Participating in a culturally-tailored home-based physical activity program may help increase physical activity in Hispanic or Latino/Latina AYA childhood cancer survivors.

Interventions

  • OTHER Discussion
  • OTHER Goal Setting
  • OTHER Interview
  • OTHER Media Intervention

Study Locations (20)

California

  • Kaiser Permanente Downey Medical Center - Downey
  • City of Hope Comprehensive Cancer Center - Duarte
  • Miller Children's and Women's Hospital Long Beach - Long Beach
  • Mattel Children's Hospital UCLA - Los Angeles
  • Valley Children's Hospital - Madera
  • UCSF Benioff Children's Hospital Oakland - Oakland
  • Kaiser Permanente-Oakland - Oakland
  • Rady Children's Hospital - San Diego - San Diego

Florida

  • Golisano Children's Hospital of Southwest Florida - Fort Myers
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital - Hollywood
  • Nemours Children's Clinic-Jacksonville - Jacksonville
  • University of Miami Miller School of Medicine-Sylvester Cancer Center - Miami
  • Miami Cancer Institute - Miami

Arizona

  • Banner Children's at Desert - Mesa
  • Phoenix Childrens Hospital - Phoenix

Arkansas

  • Arkansas Children's Hospital - Little Rock

Colorado

  • Children's Hospital Colorado - Aurora

Connecticut

  • Yale University - New Haven

Delaware

  • Alfred I duPont Hospital for Children - Wilmington

District of Columbia

  • MedStar Georgetown University Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2024-10-15
Est. Completion 2027-09-15
Phase Phase 2

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT06410209

The ClinicalTrials.gov registry entry for NCT06410209 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (83% lower). The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Discussion is the first listed.

NCT06410209 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Arizona.

Frequently Asked Questions

What is clinical trial NCT06410209 about?

NCT06410209 is a clinical study titled "A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study". This clinical trial tests the impact of a culturally-tailored home-based physical activity program on physical fitness in Hispanic or Latino/Latina adolescent and young adult (AYA) childhood cancer survivors. After treatment for cancer, some AYA survivors experience long-term effects from the cancer...

What is the current status of trial NCT06410209?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 190 participants. The study started on 2024-10-15. Estimated completion is 2027-09-15.

What conditions does trial NCT06410209 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm.

What interventions are being tested in trial NCT06410209?

The interventions under investigation include: Discussion (OTHER), Goal Setting (OTHER), Interview (OTHER), Media Intervention (OTHER).

Who is sponsoring clinical trial NCT06410209?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06410209 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.